NaHCO3: no phenol red: yes Earle’s salts (5% CO2): yes L-glutamine: no sodium pyruvate: no HEPES: no
shipped in
ambient
storage temp.
2-8°C
General description
Modification of the original MEM formulation. Contains a succinate buffering system. See formulations table for specific information. Medium may be autoclaved.
Preparation Note
Formulated to contain 9.4 grams of powder per liter of medium.
Supplement with 0.292 g/L L-glutamine, 2.2 g/L sodium bicarbonate.
NaHCO3: no phenol red: yes Earle’s salts (5% CO2): yes L-glutamine: no sodium pyruvate: no HEPES: no
components
HEPES: no sodium pyruvate: no L-glutamine: yes NaHCO3: no phenol red: yes
components
sodium pyruvate: no phenol red: yes Earle’s salts (5% CO2): yes NaHCO3: yes L-glutamine: no HEPES: no
components
glucose: yes phenol red: yes HEPES: no Hanks’ salts (2% CO2): no L-glutamine: no NaHCO3: yes Earle’s salts (5% CO2): no sodium pyruvate: no stable glutamine: no
The Journal of cell biology, 190(2), 197-207 (2010-07-28)
The signaling cascade initiated in response to DNA double-strand breaks (DSBs) has been extensively investigated in interphase cells. Here, we show that mitotic cells treated with DSB-inducing agents activate a "primary" DNA damage response (DDR) comprised of early signaling events
Through negative regulation of gene expression, microRNAs (miRNAs) can function as oncosuppressors in cancers, and can themselves show altered expression in various tumor types. Here, we have investigated medulloblastoma tumors (MBs), which arise from an early impairment of developmental processes
Cysteine proteases have been shown to be essential virulence factors and drug targets in trypanosomatids and an attractive antidisease vaccine candidate for Trypanosoma congolense. Here, we describe an important amplification of genes encoding cathepsin B-like proteases unique to T. congolense.